Why the study?
Cardiac MRI has made significant advances over the past decade, prompting a need to review its current indications and appropriateness across ESC guidelines for various cardiac pathologies.
This review advocates for more explicit ESC guideline criteria for cardiac MRI to promote its clinical use and secure specific reimbursements.
Answers are grounded in this paper and cite their sources.
May prompt explicit cMR criteria in guidelines to boost adoption and reimbursements; leaves open effects on practice without further evidence.
Cardiac MRI has made significant advances in the past decade, becoming an important technique for the evaluation of various cardiac pathologies. The aim of this document is to review the current indications for performing cardiac MRI based on the current ESC guidelines for STEMI, NSTEMI, chronic coronary artery disease, heart failure, arrhythmias, sudden cardiac death, valvular heart disease, pericardial disease and congenital heart disease. The review discusses the diagnostic and prognostic value of cMR for numerous cardiac diseases, and its important value in assessing structural heart disease and predicting arrhythmia risk. Additionally, it reflects upon the appropriateness of the guidelines and points out areas where the indications should be revised in future editions, based on the author's personal opinion. It is suggested that guideline criteria for the use of cMR should be more explicit to promote its use and lead to more specific reimbursements. However, further studies are needed to even better document the value of cMR in the future.
No takes yet. Share an insight, caveat, or question.
Bernhard Gerber (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: